LET for Fibromyalgia
A legfontosabb adatok
- Hol
- Dallas (Egyesült Államok)A helyszín megnézése
Neked szólhat?
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 65 év között vagy?
Forrás: NCT07201818: ki vehet részt
Helyszínek itt: Egyesült Államok
- UT Southwestern Medical Center in the Allied Health Physical Therapy ClinicDallas, Egyesült ÁllamokContact: Jason Zafereo, M.P.T, Ph.D.No longer taking part
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakA vizsgálat adatai
- Ki végzi
- University of Texas Southwestern Medical Center
- Azonosító
- NCT07201818
- A regiszteradat frissítve
- 2026. február 20.
- Eredeti leírás
The study is a double blinded, randomized, sham-controlled, parallel group trial conducted at UT Southwestern (UTSW) Medical Center. The purpose of this research study is to determine the effectiveness of Lymphatic Enhancement Technology (LET) treatment in patients with fibromyalgia. Participants will complete assessments of heart rate and blood pressure, pain thresholds to mechanical stimuli, and completion of quality-of-life surveys. In addition, participants will receive four treatments, one time per week, with either an active or sham LET device. Each visit will take between 45 minutes to 2 hours. A follow-up phone call or email from the study team will occur at 4 weeks after completion of the LET treatment. Total study duration is two months.A teljes eredeti leírásKevesebb
A Randomized Sham-Controlled Trial of Lymphatic Enhancement Technology in the Treatment of Fibromyalgia
The study is a double blinded, randomized, sham-controlled, parallel group trial conducted at UT Southwestern (UTSW) Medical Center. The purpose of this research study is to determine the effectiveness of Lymphatic Enhancement Technology (LET) treatment in patients with fibromyalgia. Participants will complete assessments of heart rate and blood pressure, pain thresholds to mechanical stimuli, and completion of quality-of-life surveys. In addition, participants will receive four treatments, one time per week, with either an active or sham LET device. Each visit will take between 45 minutes to 2 hours. A follow-up phone call or email from the study team will occur at 4 weeks after completion of the LET treatment. Total study duration is two months.
Bevonási feltételek: meeting the American College of Rheumatology 2016 diagnostic criteria for fibromyalgia,; female sex,; ages 18-65 years,; never received LET treatment,; an FIQ score ≥39 (moderate severity), and; no medication changes within 14 days prior to the start of the study or for the duration of the study.
Kizáró feltételek: currently receiving any other form of mind-body or exercise treatment,; active cancer or receiving cancer treatment, and; having received any steroid injections within past 3 months; active infection,; congestive heart failure,; active blood clots,; unexplained calf pain with concern for DVT,; presence of an implanted pacemaker,; pregnant or may be pregnant,.